QR-333 Completed Phase 2 Trials for Diabetic Neuropathies Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00568035 | Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy |